地黄治疗骨科疾病的研究进展——从分子机制到临床应用
Research Progress on the Treatment of Orthopedic Diseases with Rehmannia glutinosa—From Molecular Mechanisms to Clinical Applications
DOI: 10.12677/tcm.2026.151030, PDF,    科研立项经费支持
作者: 李 睿, 周显华:眉山市中医医院科研科,四川 眉山;唐 虎:眉山市中医医院医务科,四川 眉山;李 姝*:眉山市中医医院GCP办公室,四川 眉山
关键词: 地黄骨科药理作用分子机制Rehmannia glutinosa Libosch Orthopedics Pharmacologic Action Molecular Mechanism
摘要: 地黄(Rehmannia glutinosa Libosch)作为传统中药,在骨科疾病治疗中具有悠久历史。本文系统综述了地黄及其活性成分在骨关节炎、骨质疏松、类风湿性关节炎等骨科疾病中的药理作用、分子机制及临床疗效。现代药理学研究表明,梓醇、地黄苷A、毛蕊花糖苷等核心成分通过调控Hsp90β、PI3K/AKT、MCP-1/CCR2等信号通路,抑制软骨细胞凋亡、促进成骨分化、调节骨代谢平衡。临床研究证实含地黄复方(如六味地黄丸、通督地黄汤)可显著改善患者骨代谢指标及临床症状。本文为地黄治疗骨科疾病的深入研究和临床应用提供理论依据。
Abstract: Rehmannia glutinosa Libosch as a traditional Chinese medicine, has a long history in the treatment of orthopedic diseases. This article systematically reviews the pharmacological effects, molecular mechanisms and clinical efficacy of Rehmannia glutinosa and its active components in orthopedic diseases such as osteoarthritis, osteoporosis, and rheumatoid arthritis. Modern pharmacological studies have shown that core components such as zeyu alcohol, Rehmannia glycoside A, and camphor sugar glycoside can regulate the Hsp90β, PI3K/AKT, MCP-1/CCR2 signaling pathways, inhibit chondrocyte apoptosis, promote osteogenic differentiation, and regulate bone metabolic balance. Clinical studies have confirmed that compound preparations containing Rehmannia glutinosa (such as Liuwei Dihuang Pills and Tongdu Dihuang Decoction) can significantly improve patients’ bone metabolic indicators and clinical symptoms. This article provides a theoretical basis for in-depth research and clinical application of Rehmannia glutinosa in the treatment of orthopedic diseases.
文章引用:李睿, 唐虎, 周显华, 李姝. 地黄治疗骨科疾病的研究进展——从分子机制到临床应用[J]. 中医学, 2026, 15(1): 220-224. https://doi.org/10.12677/tcm.2026.151030

参考文献

[1] Zhou, Z., Zhang, B., Liu, L., Yang, J., Wang, Y., Lv, C., et al. (2025) Inhibition of Heat Shock Protein 90β by Catalpol: A Potential Therapeutic Approach for Alleviating Inflammation‐Induced Cartilage Injuries in Osteoarthritis. Advanced Science, 12, e2503909. [Google Scholar] [CrossRef] [PubMed]
[2] 刘杰, 张慧霞, 韩炜谢, 荣郑凯. 地黄苷A对成骨细胞增殖分化及MCP-1/CCR2信号通路的影响[J]. 湖南中医药大学学报, 2025, 45(4): 631-637.
[3] 杨彬, 王上增, 杨顺, 许俊杰, 陶广义. 生地黄提取物对膝骨关节炎兔软骨细胞凋亡的影响[J]. 中国医学科学院学报, 2025, 47(2): 198-206.
[4] Hu, S., Chen, G., Wang, F., Fang, Y., Wang, S., Song, Z., et al. (2025) Network Pharmacology Analysis Uncovers the Mechanism of Shudihuang-Shanzhuyu Herb Pair in Prevention and Treatment of Diabetic Osteoporosis via PI3K/AKT Pathway. Journal of Ethnopharmacology, 345, Article ID: 119581. [Google Scholar] [CrossRef] [PubMed]
[5] 贾瑞英, 梅杰, 何强, 等. 地黄梓醇调控ATDC5软骨细胞的衰老[J]. 中国组织工程研究, 2024, 28(34): 5467-5472.
[6] Xie, W., Yang, H., Guo, C., Xie, R., Yu, G. and Li, Y. (2023) Integrated Network Pharmacology and Experimental Validation Approach to Investigate the Mechanisms of Stigmasterol in the Treatment of Rheumatoid Arthritis. Drug Design, Development and Therapy, 17, 691-706. [Google Scholar] [CrossRef] [PubMed]
[7] 王小安, 魏新淇, 孙绍龙. 秦艽地黄通痹汤治疗湿热蕴毒型类风湿关节炎活动期的临床效果[J]. 中外医学研究, 2025, 23(5): 17-20.
[8] 崔源, 石林, 杜勤智, 等. 通督地黄汤治疗腰椎间盘突出症肾虚血瘀型临床观察[J]. 实用中医药杂志, 2025, 41(1): 15-17.
[9] 何珂, 朱丽华, 陆西宛. 六味地黄丸联合二甲双胍片治疗2型糖尿病临床疗效观察[J]. 中成药, 2016, 38(1): 50-52.
[10] 凤雯晴, 刘凯洋, 张嘉宁, 等. 基于网络药理学和分子对接的熟地黄治疗骨关节炎的作用机制研究[J]. 中国中药杂志, 2022, 47(19): 5336-5343.